Clinical trial
Molecular Imaging to Identify EGFR-TKIs Benefit Non-small Cell Lung Carcinoma Patients
NCT03031522 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Imaging to Identify EGFR-TKIs Benefit Non-small Cell Lung Carcinoma Patients
- Lead sponsor
- Harbin Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2014
- Completion date
- December 31, 2019
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
molecular imaging